Article
Human umbilical cord blood mononuclear cells and chorionic plate-derived mesenchymal stem cells promote axon survival in a rat model of optic nerve crush injury.
International journal of molecular medicine - 1 May 2016
Chung Sokjoong, Rho Seungsoo, Kim Gijin, Kim So-Ra, Baek Kwang-Hyun, Kang Myungseo, Lew Helen
Abstract excerpt
The use of mesenchymal stem cells (MSCs) in cell therapy in regenerative medicine has great potential, particularly in the treatment of nerve injury. Umbilical cord blood (UCB) reportedly contains stem cells, which have been widely used as a hematopoietic source and may have therapeutic potential for neurological impairment. Although ongoing research is dedicated to the management of traumatic optic nerve injury...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
